{"name":"Asuragen","permalink":"asuragen","crunchbase_url":"http://www.crunchbase.com/company/asuragen","homepage_url":"http://www.asuragen.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"support@asuragen.com","phone_number":"1-877-777-1874","description":"","created_at":"Sat Mar 13 03:46:24 UTC 2010","updated_at":"Tue Apr 20 06:07:32 UTC 2010","overview":"<p>Asuragen is a fully integrated diagnostics company focused on molecular oncology and early detection of cancer, with an emphasis on microRNA. Asuragenâ€™s current diagnostics product portfolio consists of SignatureÂ® Genetic and Oncology Testing products, as well as industry leading controls and standards engineered using its patented Armored RNAÂ® technology. In addition to its diagnostics products, Asuragen offers GLP testing services and an established cGMP manufacturing facility that allow it to span the spectrum of discovery, testing, production and commercialization.</p>","image":{"available_sizes":[[[150,51],"assets/images/resized/0008/0176/80176v1-max-150x150.jpg"],[[182,63],"assets/images/resized/0008/0176/80176v1-max-250x250.jpg"],[[182,63],"assets/images/resized/0008/0176/80176v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"$67.5M","funding_rounds":[{"round_code":"b","source_url":"http://www.asuragen.com/pdfs/1000-0064%20-%20Series%20B%20Financing.pdf","source_description":"Asuragen, Inc. Raises $18.5 Million in Series B Financing","raised_amount":18500000,"raised_currency_code":"USD","funded_year":2007,"funded_month":12,"funded_day":10,"investments":[{"company":null,"financial_org":{"name":"PTV Sciences","permalink":"ptv-sciences","image":{"available_sizes":[[[150,43],"assets/images/resized/0005/2716/52716v1-max-150x150.jpg"],[[250,71],"assets/images/resized/0005/2716/52716v1-max-250x250.jpg"],[[258,74],"assets/images/resized/0005/2716/52716v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Telegraph Hill Partners","permalink":"telegraph-hill","image":{"available_sizes":[[[111,74],"assets/images/resized/0004/8656/48656v1-max-150x150.jpg"],[[111,74],"assets/images/resized/0004/8656/48656v1-max-250x250.jpg"],[[111,74],"assets/images/resized/0004/8656/48656v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Growth Capital Fund","permalink":"growth-capital-fund","image":null},"person":null}]},{"round_code":"a","source_url":"http://asuragen.com/pdfs/49million.pdf","source_description":"Newly Launched Asuragen Closes Series A Funding of $49 million","raised_amount":49000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":6,"funded_day":1,"investments":[{"company":null,"financial_org":{"name":"Telegraph Hill Partners","permalink":"telegraph-hill","image":{"available_sizes":[[[111,74],"assets/images/resized/0004/8656/48656v1-max-150x150.jpg"],[[111,74],"assets/images/resized/0004/8656/48656v1-max-250x250.jpg"],[[111,74],"assets/images/resized/0004/8656/48656v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Growth Capital Fund","permalink":"growth-capital-fund","image":null},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"2150 Woodward St., Suite 100","address2":"","zip_code":"78744","city":"Austin","state_code":"TX","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,104],"assets/images/resized/0008/0177/80177v1-max-150x150.jpg"],[[250,174],"assets/images/resized/0008/0177/80177v1-max-250x250.jpg"],[[450,314],"assets/images/resized/0008/0177/80177v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}